semaglutide liraglutide Use of (Victoza, Saxenda) & (Ozempic, Wegovy, Rybelsus) Comes with Risk of Gastrointestinal Disorders — Donovan Hair Clinic Effect of Weekly Subcutaneous Semaglutide

However, the clinical precedent from switching between other GLP-1 medications provides some guidance

Our wellness drips run under the medical oversight of a physician or nurse practitioner who acts as the prescriber for the protocol

Current Canadian pricing for established GLP-1 medications remains substantial: Mounjaro: Approximately $300-400 monthly depending on dose Zepbound: Similar pricing structure to Mounjaro Ozempic: $200-300 monthly across different strengths Wegovy: $400-500 monthly for maintenance doses Regulatory Pathway in Canada For Pfizer's long-acting GLP-1 drug to reach Canadian patients, the company must complete clinical trials and submit a New Drug Submission to Health Canada

This glucagon-like peptide 1 receptor agonist, or GLP-1 drug, was originally approved to treat type 2 diabetes and is now increasingly prescribed to treat obesity